Laporan Laba Rugi (TTM)
Laporan Laba Rugi Arrowhead Pharmaceuticals, Inc. - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 88 | 80 | 89 | 108 | 138 | 144 | 263 | 250 | 243 | 278 | 273 | 256 | 241 | 182 | 35 | 20 | 4 | 2 | 545 | 573 |
| Change (%) | -9.26 | 11.63 | 20.77 | 28.48 | 4.44 | 82.39 | -5.12 | -2.68 | 14.43 | -1.99 | -6.08 | -6.04 | -24.51 | -80.48 | -44.61 | -81.93 | -29.60 | 21,708.36 | 5.09 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| Gross Operating Profit | 88 | 80 | 89 | 108 | 138 | 144 | 263 | 250 | 243 | 278 | 273 | 256 | 241 | 182 | 35 | 20 | 4 | 2 | 545 | 573 |
| Change (%) | -9.26 | 11.63 | 20.77 | 28.48 | 4.44 | 82.39 | -5.12 | -2.68 | 14.43 | -1.99 | -6.08 | -6.04 | -24.51 | -80.48 | -44.61 | -81.93 | -29.60 | 21,708.36 | 5.09 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| SG&A | 54 | 55 | 56 | 64 | 85 | 104 | 123 | 141 | 132 | 135 | 125 | 117 | 109 | 113 | 121 | 121 | 125 | 128 | 134 | 140 |
| Change (%) | 2.10 | 1.57 | 13.90 | 33.95 | 22.22 | 18.22 | 13.95 | -5.86 | 1.64 | -6.92 | -6.69 | -6.92 | 3.78 | 6.77 | 0.54 | 2.74 | 2.67 | 4.42 | 4.67 | |
| % of Revenue | 61.37 | 69.06 | 62.84 | 59.26 | 61.79 | 72.31 | 46.87 | 56.29 | 54.45 | 48.36 | 45.93 | 45.63 | 45.20 | 62.14 | 339.90 | 616.95 | 3,507.27 | 5,114.84 | 24.49 | 24.39 |
| R&D | 127 | 137 | 151 | 178 | 202 | 228 | 258 | 269 | 289 | 301 | 298 | 320 | 337 | 368 | 389 | 446 | 480 | 501 | 530 | 541 |
| Change (%) | 7.80 | 10.51 | 17.60 | 13.34 | 13.09 | 13.22 | 4.00 | 7.62 | 4.06 | -0.94 | 7.24 | 5.35 | 9.29 | 5.55 | 14.66 | 7.73 | 4.27 | 5.92 | 2.06 | |
| % of Revenue | 144.50 | 171.67 | 169.95 | 165.48 | 145.99 | 158.08 | 98.13 | 107.55 | 118.94 | 108.16 | 109.31 | 124.82 | 139.96 | 202.61 | 1,095.68 | 2,268.10 | 13,519.80 | 20,023.04 | 97.25 | 94.45 |
| OpEx | 181 | 192 | 207 | 242 | 287 | 333 | 382 | 409 | 422 | 436 | 424 | 437 | 446 | 481 | 509 | 567 | 605 | 628 | 664 | 681 |
| Change (%) | 6.10 | 7.95 | 16.60 | 18.77 | 15.80 | 14.79 | 7.22 | 2.99 | 3.30 | -2.79 | 3.12 | 2.07 | 7.95 | 5.84 | 11.31 | 6.66 | 3.94 | 5.62 | 2.59 | |
| % of Revenue | 205.87 | 240.73 | 232.80 | 224.75 | 207.77 | 230.38 | 144.99 | 163.84 | 173.39 | 156.52 | 155.24 | 170.45 | 185.16 | 264.75 | 1,435.58 | 2,885.05 | 17,027.06 | 25,137.88 | 121.74 | 118.84 |
| Operating Income | -93 | -112 | -118 | -134 | -149 | -188 | -119 | -160 | -179 | -157 | -151 | -181 | -205 | -299 | -474 | -547 | -601 | -626 | -119 | -108 |
| Change (%) | 20.61 | 5.33 | 13.45 | 11.00 | 26.35 | -37.06 | 34.63 | 11.87 | -11.87 | -4.20 | 19.77 | 13.57 | 46.05 | 58.23 | 15.50 | 9.85 | 4.14 | -81.06 | -8.93 | |
| % of Revenue | -105.87 | -140.73 | -132.80 | -124.75 | -107.77 | -130.38 | -44.99 | -63.84 | -73.39 | -56.52 | -55.24 | -70.45 | -85.16 | -164.75 | -1,335.58 | -2,785.05 | -16,927.06 | -25,037.88 | -21.74 | -18.84 |
| Interest Expense | -3 | -8 | -13 | -18 | -21 | -23 | -23 | -32 | -49 | -63 | -82 | |||||||||
| Change (%) | 177.50 | 65.24 | 40.28 | 13.74 | 10.49 | -0.28 | 40.86 | 50.32 | 29.60 | 30.60 | ||||||||||
| % of Revenue | -1.02 | -2.90 | -5.10 | -7.61 | -11.47 | -64.93 | -116.89 | -911.07 | -1,945.24 | -11.56 | -14.37 | |||||||||
| Net Income | -85 | -103 | -110 | -126 | -141 | -183 | -112 | -154 | -176 | -155 | -150 | -181 | -205 | -297 | -471 | -539 | -599 | -640 | -144 | -148 |
| Change (%) | 21.36 | 6.80 | 14.88 | 11.87 | 29.92 | -38.90 | 37.67 | 14.38 | -12.24 | -2.79 | 20.57 | 13.34 | 44.59 | 58.61 | 14.41 | 11.30 | 6.71 | -77.49 | 3.09 | |
| % of Revenue | -96.09 | -128.52 | -122.97 | -116.97 | -101.85 | -126.70 | -42.44 | -61.59 | -72.39 | -55.51 | -55.06 | -70.69 | -85.27 | -163.32 | -1,327.18 | -2,741.43 | -16,882.37 | -25,588.56 | -26.41 | -25.90 |
Source: Capital IQ
